HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Koichiro Tatsumi Selected Research
Koichiro Tatsumi Research Topics
Disease
62
Pulmonary Hypertension
05/2024 - 05/2002
42
Neoplasms (Cancer)
01/2024 - 05/2002
28
Pulmonary Arterial Hypertension
05/2024 - 06/2004
23
Hypoxia (Hypoxemia)
07/2023 - 05/2002
23
Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 08/2002
17
Lung Injury
03/2024 - 01/2007
15
Interstitial Lung Diseases (Interstitial Lung Disease)
05/2024 - 01/2002
13
Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2024 - 11/2014
13
Fibrosis (Cirrhosis)
03/2024 - 10/2011
13
Idiopathic Pulmonary Fibrosis
03/2024 - 06/2005
13
Obstructive Sleep Apnea
10/2023 - 03/2003
11
Inflammation (Inflammations)
01/2024 - 01/2005
11
Lung Neoplasms (Lung Cancer)
01/2021 - 06/2007
10
Mesothelioma
05/2018 - 05/2012
10
Carcinoma (Carcinomatosis)
03/2018 - 03/2002
9
Vascular Remodeling
12/2021 - 09/2006
9
Infections
01/2020 - 01/2004
9
Dyspnea (Shortness of Breath)
04/2019 - 01/2009
8
Emphysema
05/2024 - 08/2004
8
Lung Diseases (Lung Disease)
01/2024 - 08/2004
8
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 12/2002
7
Pneumonia (Pneumonitis)
07/2023 - 10/2011
6
Hemorrhage
01/2023 - 01/2015
5
Body Weight (Weight, Body)
07/2023 - 05/2002
5
Respiratory Insufficiency (Respiratory Failure)
03/2023 - 09/2016
5
Pulmonary Alveolar Proteinosis
01/2023 - 06/2010
5
Disease Progression
01/2020 - 01/2013
5
Hemoptysis
01/2020 - 09/2007
5
Apnea
01/2020 - 03/2005
5
Malignant Mesothelioma
01/2017 - 01/2008
4
Connective Tissue Diseases (Connective Tissue Disease)
01/2024 - 01/2014
4
Atherosclerosis
10/2023 - 03/2017
4
Familial Primary Pulmonary Hypertension
01/2021 - 01/2014
4
Adenocarcinoma
01/2015 - 12/2011
4
Neoplasm Metastasis (Metastasis)
01/2013 - 05/2002
3
Diabetes Mellitus
10/2023 - 11/2018
3
Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 01/2019
3
Heart Failure
04/2023 - 01/2014
3
Sarcoidosis (Schaumann Disease)
01/2022 - 01/2013
3
Pulmonary Edema
10/2020 - 03/2019
3
Adenocarcinoma of Lung
07/2017 - 12/2013
3
Asthma (Bronchial Asthma)
01/2017 - 11/2010
3
Hypercapnia
11/2016 - 02/2005
3
Lymphangioleiomyomatosis (Lymphangiomyomatosis)
05/2016 - 02/2004
3
Pathologic Constriction (Stenosis)
01/2016 - 02/2004
Drug/Important Bio-Agent (IBA)
13
Oxygen (Dioxygen)
IBA
07/2023 - 03/2005
12
Bleomycin (Blenoxane)
FDA Link
Generic
04/2023 - 01/2008
12
Cisplatin (Platino)
FDA Link
Generic
03/2018 - 12/2005
11
Biomarkers (Surrogate Marker)
IBA
01/2024 - 04/2008
9
Cytokines
IBA
03/2024 - 06/2003
9
Proteins (Proteins, Gene)
FDA Link
10/2023 - 02/2011
8
nintedanib
IBA
03/2024 - 07/2017
8
Semaxinib (SU5416)
IBA
07/2023 - 11/2007
6
Lipopolysaccharides
IBA
03/2024 - 08/2014
6
Autoantibodies
IBA
10/2023 - 04/2008
6
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2023 - 04/2008
6
Gold
IBA
01/2017 - 12/2003
5
pirfenidone
IBA
03/2024 - 07/2017
5
Warfarin (Coumadin)
FDA Link
Generic
11/2023 - 01/2017
5
Epoprostenol (Prostacyclin)
FDA Link
Generic
01/2023 - 06/2004
5
Anticoagulants
IBA
01/2023 - 06/2011
5
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
05/2022 - 11/2007
5
Anti-Bacterial Agents (Antibiotics)
IBA
07/2020 - 08/2004
5
Adrenal Cortex Hormones (Corticosteroids)
IBA
04/2018 - 11/2010
5
Fas Ligand Protein (Fas Ligand)
IBA
01/2005 - 03/2002
4
RNA (Ribonucleic Acid)
IBA
02/2024 - 09/2020
4
Antibodies
IBA
10/2023 - 01/2020
4
Vasodilator Agents (Vasodilators)
IBA
07/2022 - 03/2019
4
Interleukins
IBA
01/2022 - 01/2012
4
Phosphodiesterase 5 Inhibitors
IBA
01/2021 - 01/2012
4
p38 Mitogen-Activated Protein Kinases
IBA
09/2020 - 12/2006
4
Tyrosine Kinase Inhibitors
IBA
01/2020 - 12/2011
4
Cytotoxins (Cytolysins)
IBA
01/2019 - 06/2004
4
Midkine
IBA
09/2017 - 06/2015
4
Survivin
IBA
09/2017 - 06/2015
4
Diphosphonates (Bisphosphonates)
IBA
12/2016 - 05/2012
4
Zoledronic Acid (Zometa)
FDA Link
12/2016 - 05/2012
4
Caspases
IBA
06/2015 - 05/2012
4
Smoke
IBA
08/2014 - 04/2007
3
Matrix Metalloproteinases (MMPs)
IBA
03/2024 - 05/2002
3
Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)
IBA
01/2024 - 09/2017
3
Antigens
IBA
10/2023 - 01/2002
3
Acetaminophen (Paracetamol)
FDA Link
Generic
01/2023 - 04/2014
3
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 01/2008
3
Steroids
IBA
01/2022 - 01/2015
3
Enzymes
IBA
12/2021 - 06/2004
3
Collagen
IBA
09/2020 - 10/2011
3
riociguat
IBA
01/2020 - 09/2013
3
Metformin (Glucophage)
FDA Link
Generic
01/2017 - 07/2012
3
Endothelin Receptor Antagonists
IBA
12/2016 - 01/2012
3
lipoarabinomannan (LAM)
IBA
05/2016 - 02/2004
3
Monocrotaline
IBA
01/2016 - 12/2010
3
Pemetrexed (MTA)
FDA Link
01/2015 - 07/2012
Therapy/Procedure
45
Therapeutics
05/2024 - 03/2003
20
Endarterectomy (Thromboendarterectomy)
04/2023 - 06/2008
15
Drug Therapy (Chemotherapy)
09/2019 - 01/2007
6
Lung Transplantation
07/2021 - 02/2004
5
Radiotherapy
09/2017 - 12/2002
4
Continuous Positive Airway Pressure
01/2020 - 03/2003
4
Aftercare (After-Treatment)
05/2019 - 12/2007